Budralazine 分子结构式
HCID2463

Budralazine

N-(4-methylpent-3-en-2-ylideneamino)phthalazin-1-amine

C14H16N4240.3 g/molCAS 36798-79-5

IDENTITY

结构与身份

标准SMILES
CC(C)=CC(C)=NNc1nncc2ccccc12
InChIKey
DQGFCLJXYFXXIJ-UHFFFAOYSA-N
分子式
C14H16N4
平均分子量
240.3 g/mol
单同位素质量
240.13749653

COMPUTED

结构计算性质

已同步
XLogP
3.1
极性表面积
50.2 Ų
氢键供体
1
氢键受体
4
可旋转键
3
重原子
18
形式电荷
0
复杂度
331

PHARMACOLOGY

药理信息

MeSH Pharmacological Classification

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Drugs used to cause dilation of the blood vessels.

ALIASES

名称与别名

共 37 条
Buterazine36798-79-5BudralazinaBudralazinumS0177QHV2B1-(2-(1,3-Dimethyl-2-butenylidene)hydrazino)phthalazineDJ-14614-Methyl-3-penten-2-one (1-phthalazinyl)hydrazone1(2H)-Phthalazinone, (1,3-dimethyl-2-butenylidene)hydrazoneRefChem:917692Budralazine1-[2-(4-methylpent-3-en-2-ylidene)hydrazin-1-yl]phthalazineBudralazine [INN:JAN]Budralazinum [INN-Latin]Budralazina [INN-Spanish]DJ 14611-(2-(4-Methylpent-3-en-2-ylidene)hydrazinyl)phthalazine1-[2-(4-Methylpent-3-en-2-ylidene)hydrazinyl]phthalazineUNII-S0177QHV2BDTXSID00865833

REACTIONS

相关反应

1
HRID 261776 反应方程式

uspto-grants-1979_05 · 10.6084/m9.figshare.5104873.v1 · US04152435

查看